Delivery Order SPE2DB24D1007-SPE2DB24FBZWR

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,558.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VALTOCO 10 MG nasal sprays, with a completion date of November 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,128.54 for the supply of VALTOCO 15 MG NASAL SPRAYS. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. The award does not have a set-aside designation, indicating it was open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is associated with the company's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,458.90 for the supply of VALTOCO 20 MG NASAL SPRAYS. The contract, which has no set-aside designation, is funded by the Defense Logistics Agency, a defense agency. The award has a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYA1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,394.78 delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type, with an ultimate completion date of October 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VALTOCO 15 MG nasal sprays. The $2,124.34 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,895.55 firm-fixed-price contract is for the delivery of VALTOCO 15 MG Nasal Sprays, with a period of performance through October 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the parent company Amerisourcebergen Corporation. The $1,671.52 Firm Fixed Price Delivery Order is for the supply of VALTOCO 15 MG NASAL SPRAYS. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery...
This federal contract award, valued at $1,437.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, will be supplying the government with VALTOCO 5 MG NASAL SPRAYS. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Department of Defense (DoD) via the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $2,959.80, has a period of performance through March 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VALTOCO 10 MG NASAL SPRAYS. The firm-fixed-price delivery order, valued at $1,979.40, has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBZWR
    Delivery Order

This federal contract award, valued at $1,247.06, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4565133484 - VALTOCO 15 MG NASAL SPRAYS. The contract is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/11/24, 9:28 AM